Viz RV/LV vs Steth IO

Steth IO offers a highly intuitive and user-friendly experience by transforming a familiar smartphone into a diagnostic tool, complete with real-time visualization and easy sharing capabilities. Its mobile nature and direct patient engagement features make it readily accessible at the point of care. Viz RV/LV, while streamlining complex radiology workflows, operates more within existing hospital IT infrastructure rather than offering a novel, direct user interface experience for clinicians.

Viz RV/LV demonstrates superior clinical value with published data showing a significant 74% reduction in in-hospital mortality rates for pulmonary embolism patients. It provides highly accurate, automated RV/LV ratio measurements from CTPA scans, crucial for rapid risk stratification. While Steth IO enhances diagnostic accuracy through audio-visual data, it primarily augments traditional auscultation and lacks comparable direct patient outcome improvements in the provided information.

Steth IO offers transparent and accessible pricing, including a device purchase for $99.00 and an annual membership for Steth IO Spot at $15/month, making it a cost-effective solution. Viz RV/LV's pricing is not publicly available and typically involves high-cost enterprise-level subscriptions, ranging from $50,000 to over $1 million annually for hospitals. Although Viz.ai has CMS reimbursement, Steth IO's clear, lower-cost model provides more immediate value transparency.

Viz RV/LV is built for enterprise-scale deployment, offering seamless integration with EHR, PACS, and radiology worklist systems, and explicitly states HIPAA compliance with a Business Associate Agreement (BAA). Its robust infrastructure supports system-wide care coordination across thousands of hospitals. Steth IO, while cloud-based and mobile, indicates that the 'user is responsible for compliance' and has a 'HIPAA warning for email export,' suggesting a less comprehensive enterprise-level compliance and integration strategy.

Viz RV/LV leverages sophisticated AI algorithms for automated critical diagnostic measurements and intelligent care coordination, a pioneering approach recognized by multiple Edison Awards and inclusion in Fast Company's Most Innovative Companies. It also received the first de novo FDA approval for AI computer-aided triage. Steth IO's innovation lies in transforming a smartphone into a digital stethoscope, which is clever, but Viz.ai's consistent industry recognition for groundbreaking AI in clinical workflows sets it apart.

Viz.ai provides extensive customer support, including dedicated customer success teams, implementation experts, and 24/7 on-call clinical specialists, alongside a comprehensive support center and educational resources like 'Viz Academy.' Steth IO offers standard customer service contact via email and a one-year hardware warranty. However, it does not detail the same depth of dedicated, multi-faceted support for its users as Viz.ai.